We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 15, 2021

Effects of SGLT1/2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes

American Heart Journal

 

Additional Info

American Heart Journal
Effects of Sodium-Glucose Cotransporter 1 and 2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes: A Meta-Analysis Update
Am. Heart J 2020 Dec 29;[EPub Ahead of Print], HM Salah, SJ Al'Aref, MS Khan, M Al-Hawwas, S Vallurupalli, JL Mehta, JP Mounsey, SJ Greene, DK McGuire, RD Lopes, M Fudim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading